CCI vs OBIO · P/E 40, rev $6.57B vs rev $2.6M
Crown Castle (CCI) versus Orchestra BioMed Holdings Inc. (OBIO) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported OBIO revenue for 2024-12-31 was $2.6M. Net income was -$61.0M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. OBIO currently screens at market cap $231.7M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. OBIO currently screens at market cap $231.7M.
Not investment advice. Open the CCI and OBIO stock pages for the full models.
Not investment advice.